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Objective: To observe the effects of Bushenyiqihexue Formula (补肾益气和血方 Formula for Tonifying the 
Kidney, Replenishing qi and Harmonizing Blood, FTKRQHB) on the endometrial gland apoptosis in the 
mice with blastocyst implantation dysfunction. Methods: The mice with the first-day pregnancy were 
divided into the control, model and treatment groups, with 30 in each group, and blastocyst implantation 
dysfunction was induced by subcutaneous injection of mifepristone in the mice of the model and treatment 
groups. The pregnancy rate and implantation number of blastocysts were measured and the expressions of 
proliferating cell nuclear antigen (PCNA), Bax, Bcl-2, and activated caspase-3 were detected in all the three 
groups. Results: The model group had significantly depressed pregnancy rate, implantation number of 
blastocysts and apoptosis index, and elevated proliferation index of endometrial gland as compared with the 
control group (P<0.05 or P<0.01). Administration of FTKRQHB (the treatment group) resulted in significant 
increases in pregnancy rate, implantation number of blastocysts and apoptosis index of the endometrial gland, 
and a significant decrease in the proliferation index of the endometrial gland as compared with the model 
group (P<0.05 or P<0.01). The differences in the four indexes between the treatment group and control group 
were not significant statistically. The Bax and activated caspase-3 expressions in endometrial gland in the 
model group became significantly lower than that of the control group (P<0.01), whereas those in the 
treatment group were significant higher than that of the model group (P<0.01). However, the Bax and 
activated caspase-3 expressions in endometrial gland were similar in both treatment and control groups. 
Conclusion: Promoting the increases in Bax and activated caspase-3 expressions in the endometrial gland 
and bringing into balance between apoptosis and proliferation of the glandular cells at the implantation 
window phase by FTKRQHB may contribute to the effects of promoting the establishment of endometrial 
receptivity and improving blastocyst implantation dysfunction.  
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Blastocyst implantation dysfunction has become the 
bottlenecking factor for a successful pregnancy. 
Improving embryonic implantation by promoting the 
establishment of endometrial receptivity is one 
breakthrough in treating barrenness in clinical 
practice. The establishment of endometrial receptivity 
is chiefly characterized by apoptosis of the end- 
ometrial gland at the implantation window phase. 
FTKRQHB1has been shown in clinical practice to 
improve the embryonic implantation of the patients 
receiving multiple in vitro fertilization-embryo 
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transfer unsuccessfully. In order to explore the 
mechanism of its action, the present study on the 
effects of FTKRQHB on the establishment of 
endometrial receptivity from apoptosis of the 
endometrial gland and on the relevant regulating and 
controlling factors were carried out. 
MATERIALS AND MRTHODS 
Laboratory Animals 
The 100 male and 30 female Clean KM mice aged 8 
to 12 weeks, weighing 28 to 20 g (Conformity 
Certificate No. 19–082), were supplied by Hubei 
Provincial Anti-epidemic Station.  
Experimental Drugs  
FTKRQHB consists of Sang Ji sheng (桑寄生 
Ramulus Taxilli) 18g, Dan Shen (丹参 Radix Salviae 
Miltiorrhizae) 14g, Huang Qi (黄芪 Radix Astragali) 
9g, Dang Gui (当归 Radix Angelicae Sinensis) 9g, 
and Chuan Xiong (川芎 Rhizome Chuaxiong) 9g. 
These Chinese drugs were made into the extractum 
(3.75 mg of crude drugs/1 ml of extractum) via 
decoction and alcohol sedimentation by Institute of 
the Integration of Traditional Chinese and Western 
Medicines, Tongji Hospital. Mifepriston tablets 
(25mg/1tablet, Batch Number: 010413) made by 
Beijing Third Pharmaceutical Factory were powdered 
and dissolved in propylene glycol at a concentration 
of 0.8 mg/ml.  
Reagents 
Anti-PCNA antibody was purchased from Neomarker 
Co., U.S.A., anti-Bax antibody and anti-bel-2 anti- 
body from SantaCruz Co., U.S.A., anti-activated 
caspase-3 antibody from R&D Co., SP kit and DAB 
color kit from Beijing Zhongshan Bioengineering 
Company Limited, and the in situ cell apoptosis 
detection kits from Boehringer Mannhein Co., 
Germany.  
Grouping and Treating  
The male and female KM mice (1:2) were housed in 
a same cage for impregnation. Mating was evidenced 
by the appearance of a vaginal plug on the following 
morning, and the plugged females were designated as 
the first day of pregnancy. The mice with the first-day 
pregnancy were divided into the control, model and 
treatment groups, with 30 in each group. FTKRQHB 
was orally administered to the mice of the treatment 
group starting from the first day of pregnancy 0.2 ml/ 
a mouse, and equal volume of normal saline was 
orally administered to the mice of the control and 
model groups. Mifepristone solution was sub- 
cutaneously administered to the mice of the model 
and treatment groups 0.1 ml/a mouse, and equal 
volume of propylene glycol was subcutaneously 
administered to the mice of the control group from 7 
a.m. to 8 a.m. on the fourth day of pregnancy. 10 
mice of each group were sacrificed by cervical 
dislocating from 21:30 to 22:00 on the fourth day of 
pregnancy, and the uteri were excised. One uterine 
horn was fixed in 4% paraformal-dehyde and 
embedded with paraffin, and the other uterine horn 
was kept in liquid nitrogen. The remaining 20 mice of 
each group were sacrificed on the seventh day of 
pregnancy to observe the pregnancy rate and imp- 
lantation number of blastocysts. 
Detection of PCNA, Bax, Bcl-2, and Activated 
Caspase-3 
Immunohistochemistry SP method was adopted for 
detection of PCNA, Bax, Bcl-2, and activated 
caspase-3. The PCNA positively stained cells (cells 
with pale brown stained nuclei) were counted in 10 
random high-power fields of each sample under the 
light microscope. The proliferative index was the 
percentage of cells positive for PCNA. The cells 
positive for Bax, activated caspase-3 and Bcl-2 were 
characterized by pale brown stained cytoplasm. 
HPIAS-1000 pathology picture analysis system 
produced by Qianping Audiovisual Company of 
Tongji Medical College was used to measure their 
expressions, assessed by integrated luminosity of the 
positive signal.  
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Detection of Apoptotic Cells  
The TUNEL method was used to assess the apoptotic 
cells. The positive nuclei with pale brown color were 
counted by 10 random high-power fields of each 
sample under the light microscope. The apoptotic 
index was the percentage of the positive cells. 
Statistical Analysis 
All the data were expressed as mean ± SD. Student’s 
t-test and Chi-square test were performed to 
determine the significance of the difference between 
the covariates. The level of statistical significance 
was set as P<0.05. All the analyses were conducted 
with SPSS11.5 statistical software.  
RESULTS 
Pregnancy Rate and Mean Implantation Number 
of Blastocysts in All the Groups 
As shown in table 1, the pregnancy rate and mean 
implantation number of blastocysts in the model 
group were significantly lower than those in the 
control group (P<0.05 or P<0.01), the pregnancy rate 
and mean implantation number of blastocysts in the 
treatment group were significantly higher than those 
in the model group (P<0.05 or P<0.01), and the mean 
implantation number of blastocysts in the treatment 
group was significantly lower than that in the control 
group (P<0.05).  
Table 1. Pregnancy rate and mean implantation number of blastocysts in different groups ( x ±s) 
Group Cases Pregnancy rate (%) Mean implantation number of blastocysts 
Control   20 90 14.67±1.35 
Model  20  25*    7.67±1.34** 
Treatment  20  55△    12.31±0.75*△△ 
Note: *P <0.05 and **P<0.01 as compared with the control group; and △P <0.05 and △△P <0.01 as compared with the model 
group. 
Proliferative and Apoptotic Status of Endometrium  
As shown in table 2, the proliferative index of the 
endometrial gland in the model group was 
significantly higher than that in the control group 
(P<0.01), and the proliferative index of the 
endometrial gland in the treatment group was 
significantly lower than that in the model group. The 
difference in proliferative index of the endometrial 
gland between the treatment group and the control 
group was not significant. However，the apoptotic 
index of the endometrial gland in the model group 
was significantly lower than that in the control group 
(P<0.05), and the apoptotic index of the endometrial 
gland in the treatment group was significantly higher 
than that in the model group (P<0.01). The difference 
in apoptotic index of the endometrial gland between 
the treatment group and the control group was not 
significant. The differences in the proliferative index 
and apoptotic index of the endometrial stroma among 
the three groups were not statistically significant. 
Table 2. Proliferative and apoptotic status of endometrium ( x ±s) 
Proliferative index Apoptotic index  Group  Cases 
Gland Stroma Gland  Stroma  
Control  10 0.131±0.06 0.474±0.02 0.193±0.09 0.037±0.008 
Model  10   0.368±0.05** 0.443±0.04 0.077±0.01* 0.040±0.008 
Treatment  10  0.185±0.02△ 0.450±0.02 0.120±0.02△ 0.036±0.007 
Note: *P<0.05 and **P<0.01 as compared with the control group; and △P<0.01 as compared with the model group. 
Expressions of Bax, Bcl-2, and Activated Caspase- 
3 in Endometrium of the Three Groups 
Expressions of Bax, Bcl-2 and activated caspase-3 
were assessed by integrated luminosity of the positive 
signal. The mean integrated luminosity of Bax 
protein in the model group was significantly lower 
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than that in the control group (P<0.01), and the mean 
integrated luminosity of Bax protein in the treatment 
group was significantly higher than that in the model 
group (P<0.01). The difference in the mean int- 
egrated luminosity of Bax protein between the 
treatment group and control group was not 
statistically significant. The difference in the mean 
integrated luminosity of Bcl-2 among the three 
groups was not statistically significant. The mean 
integrated luminosity of activated caspase-3 was 
significantly lower than that in the control group 
(P<0.01), and the mean integrated luminosity of 
activated caspase-3 in the treatment group was 
significantly higher than that in the model group 
(P<0.05) but significantly lower than that in the 
control group (P<0.05). 
Table 3. Mean integrated luminosity of Bax, Bcl-2 and activated caspase-3 
in endometrium of the three groups ( x ±s) 
Group  Cases Bax Bcl-2 activated caspase-3 
Control  10 36.73±7.63 17.20±22.9 30.73±1.30 
Model  10   17.35±1.50** 10.63±6.00  22.14±2.58** 
Treatment 10   28.99±7.42△△  11.02±11.91  25.99±2.83*△ 
Note: *P <0.05 and **P <0.01 as compared with the control group; and △P <0.05; △△P <0.01 as compared with the model group.   
DISCUSSION 
The complex and fine changes usually take place in 
the endometrium at the implantation window phase, 
which form a favorable microenvironment for the 
blastocyst implantation. The apoptosis of the 
glandular epithelium occurring exactly at this phase 
is closely linked to establishment of the endometrial 
receptivity. Von RU et al.1 found that the apoptosis 
occurring in the glandular epithelium of the 
endometrial stratum basale during on the 19–20th day 
of the menstrual cycle, subsequently the apoptosis 
took place in the glandular epithelium of the 
functional basale. At this time, the proliferative 
reaction and Bcl-2 expression occurred only in the 
stroma. The glandular apoptosis occurring at this 
phase are supposed to play an important role in 
establishment of the endometrial receptivity. Both the 
disappearance of Bcl-2 expression and the increase of 
Bax expression are the inducing factors for glandular 
apoptosis at this phase. Gao F et al. found that the 
endometrial gland revealed the apoptosis in the 
afternoon 4 days after gestation, that is, the prophase 
of blastocyst implantation in the mice (the blastocyst 
implantation in mice started at 22 p.m. to 24 p.m. on 
the 4th day after gestation).2 After the mice were 
treated by mifepristone, the apoptosis of the 
glandular cells was markedly decreased, thus 
affecting establishment of the endometrial receptivity. 
In FTKKQHB, Sang Ji sheng (桑寄生  Ramulus 
Taxilli) can exert the effect of invigorating the kidney 
essence, which is used as the sovereign ingredient; 
Huang Qi (黄芪 Radix Astragali) is used as the 
minister ingredient for invigorating the spleen that 
provides the material basis for the acquired con- 
stitution to nourish the congenital essence for the 
fetus; and the drugs for nourishing blood, regulating 
blood and harmonizing blood, such as Dan Shen (丹
参 Radix Salviae Miltiorrhizae), Dang Gui (当归 
Radix Angelicae Sinensis), and Chuan Xiong (川芎 
Rhizome Chuaxiong), are added to regulate the 
Chong and Ren channels. In clinical practice, the 
therapeutic results are satisfactory. 3 The increasing 
of pregnancy rate correlates closely with the 
glandular apoptosis and the establishment of the 
endometrial receptivity. Generally, the blastocyst 
implantation in the mice comes on during 22 p.m. to 
24 p.m. in the 4th day of gestation. Sampling in this 
series was carried out during 21:30 p.m. to 22 p.m., 
namely, at the time exactly prior to the blastocyst 
implantation in the mice. Because whether the 
endometrial receptivity is established at this phase or 
not is very important to the blastocyst implantation. It 
is found in the present experiment that subcutaneous 
injection of mifepristone could produce a remarkable 
decrease in pregnancy rate, implantation number of 
blastocysts and apoptosis of the endometrial gland in 
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the mice, with a relative increase of the proliferation; 
while the mice previously treated by FTKRQHB 
showed a remarkable elevation in apoptosis of the 
endometrial gland and a reduction of the proliferation 
mainly occurring in the stroma, with no significant 
differences in the apoptosis and proliferation as 
compared with the normal mice, indicating that 
FTKRQHB could improve the imbalance between 
apoptosis and proliferation of the endometrial gland 
cells in the mice with blastocyst implantation 
dysfunction, and promote the establishment of the 
endometrial receptivity.  
The Bcl-2 protein family is the prevailing regulator 
of apoptosis. Bcl-2 and Bax have been studied 
thoroughly and deliberately. Bax can form the 
homodimers itself, with the pro-apoptotic activity. 
However, Bax can also form the heterodimers with 
Bcl-2 when Bcl-2 is overexpressed, showing the 
anti-apoptotic activity. Activation of the caspases 
family is indispensable to their meditating effect on 
apoptosis. Caspase-3 is a key kinase that initiates 
apoptosis and also the main effect molecule for 
apoptosis. Apoptosis is irrevocably launched when 
caspase-3 is processed into active enzymes.  
It was found in the present study that high expression 
of Bax at the implantation window phase occurred in 
the glandular epithelium and the surface epithelium 
of the endometrium, especially in the glandular 
epithelium; but the Bcl-2 expression occurred in the 
stroma. Mifepristone could produce a decrease in 
Bax expression in the glandular epithelium but 
showed no effect on Bcl-2 expression in the stroma. 
FTKRQHB was able to improve the low expression 
of Bax in the glandular cells of the endometrium in 
mice with blastocyst implantation dysfunction. The 
activated caspase-3 expression at the implantation 
window phase occurred in both the glandular 
epithelium and the surface epithelium of the 
endometrium, especially in the glandular epithelium, 
but it was hardly present in the stroma. The activated 
caspase-3 expression in the glandular epithelium was 
significantly inhibited after mifepristone was adm- 
inistered on the 4th day of gestation; however, 
FTKRQHB could significantly improve the activated 
caspase-3 expression in the glandular epithelium.  
The results from the present study showed that the 
Bax and activated caspase-3 were largely expressed 
in the glandular epithelium, and the apoptosis 
occurred at the implantation window phase; the 
reducing of Bax and activated caspase-3 expressions 
by mifepristone might be one of the mechanisms 
leading to poor apoptosis and sthenic proliferation of 
the glandular cells; and FTKRQHB could exert the 
effect of regulating the imbalance between apoptosis 
and proliferation of the glandular cells to promote 
establishment of the endometrial receptivity and 
improve blastocyst implantation dysfunction by way 
of promoting the expressions of Bax and activated 
caspase-3 in the gland.  
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